Transcept Pharmaceuticals
Focuses on the development of proprietary products that address therapeutic needs in the field of neuroscience.
Launch date
Employees
Market cap
-
Enterprise valuation
€145—218m (Dealroom.co estimates Mar 2007.)
Corte Madera California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Series A | ||
$40.0m | Series D | ||
| N/A | N/A | IPO | |
N/A | Acquisition | ||
| Total Funding | €36.4m | ||
